Trial Profile
A Phase I/II Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT [terminal deoxynucleotidyl transferase]-Positive Leukemia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cordycepin (Primary) ; Pentostatin (Primary)
- Indications Leukaemia
- Focus Adverse reactions
- Sponsors OncoVista
- 29 Jul 2008 New trial record.
- 23 Jul 2008 Patient recruitment has begun according to Oncovista media release.